Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Futamura

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 22, 2010
Aripiprazole attenuates established behavioral sensitization induced by methamphetamineTakashi Futamura, Satoshi Akiyama, Haruhiko Sugino, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Neuropsychopharmacology Reports|June 26, 2024
Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse modelsNaoki Amada, Shinji Sato, Dai Ishikawa, et al.
Neuropsychopharmacology Reports|March 7, 2026
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in RatsNaoki Amada, Mai Nakamura, Yuta Ohgi, et al.
Neuropsychopharmacology Reports|January 17, 2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in miceNaoki Amada, Tsuyoshi Hirose, Mikio Suzuki, et al.
Psychopharmacology|July 28, 2017
Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamineMin Ma, Qian Ren, Yuko Fujita, et al.
Neuropsychopharmacology Reports|September 6, 2019
Brexpiprazole has a low risk of dopamine D<sub>2</sub> receptor sensitization and inhibits rebound phenomena related to D<sub>2</sub> and serotonin 5-HT<sub>2A</sub> receptors in ratsNaoki Amada, Hitomi Akazawa, Yuta Ohgi, et al.
Psychopharmacology|November 16, 2016
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammationMin Ma, Qian Ren, Chun Yang, et al.
Scientific Reports|December 20, 2016
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signalingMin Ma, Qian Ren, Chun Yang, et al.
Journal of Neurochemistry|August 15, 2006
Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatmentMakoto Takahashi, Akiyoshi Kakita, Takashi Futamura, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 22, 2010
Aripiprazole attenuates established behavioral sensitization induced by methamphetamineTakashi Futamura, Satoshi Akiyama, Haruhiko Sugino, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Neuropsychopharmacology Reports|June 26, 2024
Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse modelsNaoki Amada, Shinji Sato, Dai Ishikawa, et al.
Neuropsychopharmacology Reports|March 7, 2026
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in RatsNaoki Amada, Mai Nakamura, Yuta Ohgi, et al.
Neuropsychopharmacology Reports|January 17, 2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in miceNaoki Amada, Tsuyoshi Hirose, Mikio Suzuki, et al.
Psychopharmacology|July 28, 2017
Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamineMin Ma, Qian Ren, Yuko Fujita, et al.
Neuropsychopharmacology Reports|September 6, 2019
Brexpiprazole has a low risk of dopamine D<sub>2</sub> receptor sensitization and inhibits rebound phenomena related to D<sub>2</sub> and serotonin 5-HT<sub>2A</sub> receptors in ratsNaoki Amada, Hitomi Akazawa, Yuta Ohgi, et al.
Psychopharmacology|November 16, 2016
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammationMin Ma, Qian Ren, Chun Yang, et al.
Scientific Reports|December 20, 2016
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signalingMin Ma, Qian Ren, Chun Yang, et al.
Journal of Neurochemistry|August 15, 2006
Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatmentMakoto Takahashi, Akiyoshi Kakita, Takashi Futamura, et al.
Pageof 3